▼ SELL
$ Value
$602
Shares
240
Price
$3
Filed
Mar 26
Insider
Name
Smalling Ralph
Title
Head of Regulatory
CIK
0001983288
Roles
Officer
Transaction Details
Transaction Date
2026-03-25
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
68,073
Footnotes
Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units.
Filing Info
Smalling Ralph's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-25 | GNLX | ▼ | $602 |
| 2026-03-24 | GNLX | ▼ | $835 |
| 2025-12-05 | GNLX | ▼ | $774 |
| 2025-11-17 | GNLX | ▼ | $2K |
| 2025-09-03 | GNLX | ▼ | $2K |
| 2025-09-01 | GNLX | A | $0 |
| 2025-09-01 | GNLX | D | — |
| 2025-09-01 | GNLX | A | — |
| 2025-08-27 | GNLX | A | $0 |
| 2025-08-27 | GNLX | A | $0 |
Other Insiders at GNLX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Yu Yong / Cappello Joseph
SVP, Clinical Development
|
— | $2K | 2026-03-24 |
|
Zindrick Thomas
President and CEO
|
— | $9K | 2026-03-24 |
| Thomas John | — | $29K | 2026-03-02 |
|
Smalling Ralph
Head of Regulatory
|
— | $835 | 2026-03-24 |